GlassScriptPhysician profile
Devon Danae Capristo
NPI 1487193421
$798.84
in general payments reported to CMS, 2019-2025
17 companies · $34.90 in 2025
The $34.90 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $744 · 2023: $20.41 · 2025: $34.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $141.15 | 2021 | |
| Antares Pharma, INC. | $92.19 | 2021 | |
| Medtronic, INC. | $76.99 | 2021 | |
| Xeris Pharmaceuticals, INC. | $74.48 | 2021 | |
| Dexcom, INC. | $64.85 | 2021 | |
| Sanofi-Aventis U.S. LLC | $49.98 | 2021 | |
| Ibsa Pharma INC. | $42.99 | 2021 | |
| Novo Nordisk INC | $39.47 | 2021 | |
| Intuitive Surgical, INC. | $34.90 | 2025 | |
| Corcept Therapeutics | $30.22 | 2021 | |
| Abbvie INC. | $29.14 | 2021 | |
| Alexion Pharmaceuticals, INC. | $22.96 | 2021 | |
| Alfasigma USA, INC. | $21.00 | 2021 | |
| Roche Diabetes Care, INC. | $20.74 | 2021 | |
| Alkermes, INC. | $20.41 | 2023 | Aristada, Lybalvi |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20.06 | 2021 | |
| Recordati_rare_diseases_inc. | $17.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Capristo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.